Clinical Trial Update: A Clinical Trial to Access Pharmacokinetic Profiles and Safety of IVL3003. [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial evaluating the pharmacokinetics and safety of IVL3003 in Alzheimer disease is currently active but not recruiting, sponsored by…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• IVL3003

Snippet

Sponsor: Inventage Lab., Inc. | Conditions: Alzheimer Disease | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING